Forte Biosciences, Inc.FBRXNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-35.44M
↓ 23% below average
Average (9y)
$-28.78M
Historical baseline
Range
High:$-4.06M
Low:$-46.43M
CAGR
+5.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-35.44M | -9.1% |
| 2023 | $-32.48M | -134.3% |
| 2022 | $-13.86M | +35.4% |
| 2021 | $-21.45M | +53.8% |
| 2020 | $-46.43M | -1044.2% |
| 2019 | $-4.06M | +90.7% |
| 2018 | $-43.69M | -19.0% |
| 2017 | $-36.70M | -17.8% |
| 2016 | $-31.17M | -38.6% |
| 2015 | $-22.48M | - |